Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®

Anagre Cap. in Patients With High-Risk Essential Thrombocythemia

NCT03232177 ·Status: COMPLETED ·Phase: PHASE4

A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

NCT02323178 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia

NCT01467661 ·Status: COMPLETED ·Phase: PHASE3

Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)

NCT03123588 ·Status: TERMINATED ·Phase: PHASE2

Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.

NCT01791101 ·Status: COMPLETED ·Phase: PHASE2

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms

NCT04192916 ·Status: COMPLETED

Effect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential Thrombocythaemia

NCT01214915 ·Status: COMPLETED ·Phase: PHASE3

SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications

NCT04539678 ·Status: COMPLETED

Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia

NCT03638817 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

NCT03025698 ·Status: COMPLETED ·Phase: PHASE2

Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)

NCT02216084 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP

NCT03102593 ·Status: COMPLETED ·Phase: PHASE2

Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures

NCT00678587 ·Status: TERMINATED ·Phase: PHASE3

Evaluation of the Safety and Immunogenicity of Autologous Thrombosomes® in Healthy Human Subjects; A Microdose Escalation Study (Cohorts 1 - 4) and Repeat Microdose Immunogenicity Study (Cohort 5)

NCT02223117 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion

NCT01955811 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency

NCT02065882 ·Status: COMPLETED ·Phase: PHASE3

Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects

NCT02404025 ·Status: COMPLETED ·Phase: PHASE2

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

NCT02566603 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure

NCT02912884 ·Status: COMPLETED

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

NCT04225156 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia

NCT02227693 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031

NCT03573882 ·Status: TERMINATED ·Phase: PHASE3

Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab

NCT03384277 ·Status: COMPLETED ·Phase: PHASE4

A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET

NCT05482971 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease

NCT01133860 ·Status: COMPLETED ·Phase: PHASE2